Both ISH and IHC data are in strong agreement across and further, these observations are in line with our in vitro (and in silico) RD3 transcription and translation data affirming that RD3 loss is acquired in NB cells that survive IMCT. This evidence concerns the gene RD3 and neuroblastoma.